Radius Health, Inc.
RDUS
RDUS was delisted on the 12th of August, 2022.
151 hedge funds and large institutions have $2.16B invested in Radius Health, Inc. in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 30 closing their positions.
63% more call options, than puts
Call options by funds: $44.7M | Put options by funds: $27.4M
47% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 38
28% more capital invested
Capital invested by funds: $1.69B → $2.16B (+$472M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 152 → 151 (-1)
3% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$118M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$31.2M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$21.8M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$21.6M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$37M |
| 2 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$26.7M |
| 3 |
O
OppenheimerFunds
New York
|
-$11.7M |
| 4 |
PA
Perceptive Advisors
New York
|
-$10.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.97M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
176
Parallax Volatility Advisers
San Francisco,
California
| – | -$139K | -3,636 | Closed |
|
|
QT
177
Quantbot Technologies
New York
| – | -$81K | -2,108 | Closed |
|
178
Group One Trading
Chicago,
Illinois
| – | -$54.2K | -1,418 | Closed |
|
|
CSS
179
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$54K | -1,400 | Closed |
|
180
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$8K | -210 | Closed |
|
RDUS Hedge Fund Activity: Q2 2017 in Review
151 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q2 2017, worth a combined $2.16B — up 28% from $1.69B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of RDUS and 29 opened new positions — a net loss of 1 holder — while 38 trimmed existing stakes and 56 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $118M. The largest seller was Jennison Associates, exiting entirely with an estimated $37M sold.
- 151 institutional investors held Radius Health, Inc. (RDUS) as of Q2 2017, down from 152 in Q1 2017.
- Funds reported $2.16B of Radius Health, Inc. stock for Q2 2017, up 28% quarter-over-quarter.
- 29 funds opened new Radius Health, Inc. positions in Q2 2017 and 30 closed out, a net change of -1 holder.
- The largest Radius Health, Inc. buyer in Q2 2017 was T. Rowe Price Associates, an estimated $118M added.
- The largest Radius Health, Inc. seller in Q2 2017 was Jennison Associates, an estimated $37M sold.
Based on aggregated 13F filings for Q2 2017.